National magazine Newsweek selected Jupiter Medical Center as one of the World’s Best Hospitals for 2021 in its annual ranking of 164,500 hospitals around the globe and over 6,000 throughout the U.S. According to Newsweek, the hospitals depicted on its highly anticipated annual ranking rise above the rest in a number of areas including consistent medical excellence, exceptional physicians, top nursing care, support staff expertise, and state-of-the-art technology.

Right on the heels of the prestigious Newsweek announcement comes another lofty accolade as the Centers for Medicare & Medicaid Services awarded Jupiter Medical Center a 5-Star Rating for Overall Hospital Quality. Jupiter Medical Center is the only hospital in Palm Beach, Martin, St. Lucie and Indian River counties to be awarded this top level grade of care.


Cleveland Clinic Martin Health welcomes board-certified otolaryngologist Tony Reisman, M.D. Dr. Reisman will also serve as the Department Chair for Ear, Nose and Throat Surgery at Martin Health.

Dr. Reisman completed an otolaryngology residency program at University Hospitals of Cleveland. Prior to residency, he completed his surgical internship at Washington University in St. Louis and his medical training at The Chicago Medical School. Dr. Reisman completed his premedical undergraduate degree at Washington University in St. Louis.
 
Prior to joining Martin Health, Dr. Reisman was a staff physician at Cleveland Clinic Head and Neck Institute in Ohio. He was also previously a staff physician at Case Western University Hospitals in Cleveland. In each of these roles, Dr. Reisman has educated many residents in training.


The Palm Beach Health Network announced that five team members have been honored by Tenet Healthcare as part of its annual recognition program. These individuals are “Tenet Hero Nominees” for their incredible contributions in 2020. Across the Palm Beach Health Network, the following team members received this prestigious recognition.

• Cat Dalberg, Employee Health Nurse, Delray Medical Center
• Rebecca Washam, Registered Nurse, Oncology, Good
Samaritan Medical Center
• Cheryl Morkan, Assistant Nurse Manager, Cardiac Unit,
Palm Beach Gardens Medical Center
• Rich Avato, Systems Analyst, St. Mary’s Medical Center
& Palm Beach Children’s Hospital
• Kelley Swannick, NICU Nurse, West Boca Medical Center


Trulieve Cannabis Corp., a leading and top-performing cannabis company in the United States, announced it has been named a winner of a Silver Stevie® Award for Achievement in Growth in the 19th Annual American Business Awards®. The awards recognize businesses that have excelled in further developing their operations through various avenues such as mergers and acquisitions and corporate expansion.

"After an unprecedented 2020, we are proud to be recognized for our growth and expansion into new markets," said Kim Rivers, CEO of Trulieve. "We look forward to building on this momentum as we drive further expansion across North America, including operations in Pennsylvania and the opening of Massachusetts in our northeast hub, bringing our high-quality cannabis products and unmatched customer service to more patients and consumers."


Holy Cross Health is now offering a new miniaturized, wireless monitoring sensor to manage heart failure. The Abbott CardioMEMS™ HF System is the first and only FDA-approved heart failure monitoring device that has been clinically proven to significantly reduce hospital admissions when used by physicians to manage heart failure.

Heart failure is the leading cause of hospitalization for Americans over age 65. The device allows patients to remotely share daily sensor readings from their homes to their health care providers, allowing for personalized care to reduce the likelihood of hospitalization. Innovative telehealth, like the CardioMEMS HF System, reduces the need for in-person appointments. Data from a recent clinical trial found that the remote monitoring technology reduces heart failure hospital admissions by up to 58 percent.
 
Heart failure occurs when the heart is unable to pump enough blood to meet the body’s demands. The CardioMEMS HF System features a sensor that is implanted in the pulmonary artery (PA) during a minimally invasive procedure. Increased PA pressures appear before weight and blood pressure changes, which are often used as indirect measures of worsening heart failure.
 
The CardioMEMS HF System, from global health care leader Abbott, is approved by the U.S. Food and Drug Administration (FDA) for commercial use in the U.S. The GUIDE-HF clinical trial followed the CHAMPION trial, which studied the effectiveness of the CardioMEMS HF System in New York Heart Association (NYHA) Functional Classification System class III heart failure patients who had been hospitalized for heart failure in the previous 12 months.